Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Shingrix
Pharma
Big Pharma reworks China strategy, and job cuts are part of it
In the last few months of 2023, Pfizer, GSK, Sanofi and Biogen have tapped local partners to help commercialize their products in China.
Angus Liu
Dec 22, 2023 8:22am
GSK crushed Pfizer in first round of RSV vaccine showdown
Nov 1, 2023 10:43am
ESMO: Searching for the perfect cup of pharma-branded espress-MO
Oct 20, 2023 7:59am
GSK partners up with Zhifei to market Shingrix in China
Oct 9, 2023 11:20am
GSK invests €250M in vaccine manufacturing for Shingrix, Arexvy
Sep 1, 2023 8:25am
Moderna, GSK and Glenmark—Fierce Pharma Asia
Aug 25, 2023 9:20am